Cambiar Investors LLC Cuts Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Cambiar Investors LLC lessened its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 19.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,622 shares of the company's stock after selling 7,170 shares during the period. Cambiar Investors LLC owned about 0.05% of Molina Healthcare worth $11,064,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Molina Healthcare by 18.4% during the 1st quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company's stock worth $2,151,448,000 after buying an additional 1,001,372 shares in the last quarter. Norges Bank acquired a new position in Molina Healthcare during the 4th quarter worth about $214,801,000. Durable Capital Partners LP acquired a new position in Molina Healthcare during the 1st quarter worth about $214,363,000. Invesco Ltd. lifted its position in Molina Healthcare by 151.6% during the 1st quarter. Invesco Ltd. now owns 893,693 shares of the company's stock worth $298,128,000 after buying an additional 538,493 shares in the last quarter. Finally, State Street Corp lifted its position in Molina Healthcare by 25.6% during the 1st quarter. State Street Corp now owns 2,457,008 shares of the company's stock worth $819,633,000 after buying an additional 501,107 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Insider Activity

In other news, CFO Mark Lowell Keim sold 15,000 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Richard M. Schapiro sold 1,000 shares of the company's stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Mark Lowell Keim sold 15,000 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares in the company, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on MOH shares. Wells Fargo & Company upped their price target on shares of Molina Healthcare from $420.00 to $440.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 20th. Cantor Fitzgerald restated an "overweight" rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday. Truist Financial upped their target price on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a "buy" rating in a research report on Tuesday, February 20th. Barclays started coverage on shares of Molina Healthcare in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $437.00 target price on the stock. Finally, UBS Group upped their price target on Molina Healthcare from $350.00 to $380.00 and gave the company a "neutral" rating in a research note on Thursday, December 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Molina Healthcare presently has an average rating of "Hold" and an average target price of $395.82.

Molina Healthcare Stock Up 0.4 %

NYSE:MOH traded up $1.47 on Friday, hitting $376.77. 313,593 shares of the company's stock were exchanged, compared to its average volume of 357,235. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. The firm has a 50-day moving average price of $392.68 and a 200-day moving average price of $368.93. The company has a market cap of $22.07 billion, a P/E ratio of 20.06, a price-to-earnings-growth ratio of 1.06 and a beta of 0.47. Molina Healthcare, Inc. has a 52 week low of $266.35 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.31 by $0.07. The company had revenue of $9.05 billion for the quarter, compared to analysts' expectations of $8.35 billion. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. Molina Healthcare's quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.10 EPS. As a group, analysts expect that Molina Healthcare, Inc. will post 23.62 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.